The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s ...

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...

Samaritan Medical Center has announced that its Pain Management Center will close its door at the end of next month. In an ...

If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.

The FDA approves suzetrigine, a non-opioid pain medication, offering a safer alternative to opioids for pain management, ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

新泽西州罗斯兰 - 市值1.01亿美元的先进药物输送仪器开发商Milestone Scientific Inc. (NYSE: MLSS)宣布在领先的疼痛管理诊所Advanced Spine and Pain Management商业推出其CompuFlo®硬膜外麻醉系统。这一进展是在与Varinder ...

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...